Aug 24, 2026 9:25am EDT Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Aug 13, 2026 4:05pm EDT Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 13, 2026 4:30 pm EDT Capricor Therapeutics Second Quarter 2026 Financial Results and Corporate Update Conference Call